Solubilizers for Standard Applications
Health Care Excipients
About 40% of new chemical entities invented as potential disease relevant APIs are poorly water soluble and cannot be absorbed effectively in the gastrointestinal tract due to their complex chemical structures or absorption profiles resulting into their failure. This increases the burden on pharmaceutical companies not only in financial aspect but also, they lose their competitive advantage and speed to the market. The poor bioavailability of APIs is not only responsible for reduced drug efficacy but also may cause undesirable side effects upon administration.
How can Clariant help you to get a solution? We offer a wide range of solubilizers that will increase the API performance
The pharmaceutical formulators can increase the bioavailability of the Active Pharmaceutical ingredient (API) by using solubility enhancement excipients with the benefit of speeding the time to market